R Redfield

1.1k total citations
11 papers, 924 citations indexed

About

R Redfield is a scholar working on Immunology, Virology and Epidemiology. According to data from OpenAlex, R Redfield has authored 11 papers receiving a total of 924 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 5 papers in Virology and 3 papers in Epidemiology. Recurrent topics in R Redfield's work include HIV Research and Treatment (5 papers), T-cell and Retrovirus Studies (5 papers) and Immune Cell Function and Interaction (5 papers). R Redfield is often cited by papers focused on HIV Research and Treatment (5 papers), T-cell and Retrovirus Studies (5 papers) and Immune Cell Function and Interaction (5 papers). R Redfield collaborates with scholars based in United States. R Redfield's co-authors include Robert Yarchoan, S Broder, S. Zaki Salahuddin, J E Groopman, R C Gallo, A S Fauci, G M Shearer, Charles S. Via, Daniel Bernstein and Robert C. Gallo and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and The Journal of Immunology.

In The Last Decade

R Redfield

11 papers receiving 868 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R Redfield United States 8 597 453 322 222 88 11 924
J S McDougal United States 11 480 0.8× 488 1.1× 255 0.8× 164 0.7× 56 0.6× 20 823
J E Groopman United States 9 484 0.8× 466 1.0× 364 1.1× 238 1.1× 89 1.0× 9 1.0k
SZ Salahuddin United States 7 398 0.7× 281 0.6× 260 0.8× 219 1.0× 55 0.6× 9 672
Eva-Maria Fenyö Sweden 10 750 1.3× 310 0.7× 474 1.5× 185 0.8× 38 0.4× 16 870
P Nishanian United States 13 756 1.3× 561 1.2× 395 1.2× 236 1.1× 92 1.0× 13 1.1k
Bert J. M. Al Netherlands 7 896 1.5× 605 1.3× 444 1.4× 231 1.0× 37 0.4× 9 1.1k
John F. Krowka United States 18 775 1.3× 771 1.7× 374 1.2× 263 1.2× 75 0.9× 30 1.3k
J. C. Gluckman France 10 469 0.8× 321 0.7× 190 0.6× 153 0.7× 69 0.8× 21 664
N I Stocks United States 11 675 1.1× 768 1.7× 294 0.9× 314 1.4× 50 0.6× 13 1.2k
Dale F. Hirschkorn United States 15 202 0.3× 366 0.8× 218 0.7× 296 1.3× 51 0.6× 19 880

Countries citing papers authored by R Redfield

Since Specialization
Citations

This map shows the geographic impact of R Redfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Redfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Redfield more than expected).

Fields of papers citing papers by R Redfield

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Redfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Redfield. The network helps show where R Redfield may publish in the future.

Co-authorship network of co-authors of R Redfield

This figure shows the co-authorship network connecting the top 25 collaborators of R Redfield. A scholar is included among the top collaborators of R Redfield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Redfield. R Redfield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Patel, Deven, et al.. (2013). B112 An Evaluation of Distance and its Impact on Long-term Follow up Outcomes in a Rural HIV Clinic in Northern Haiti. JAIDS Journal of Acquired Immune Deficiency Syndromes. 62(Supplement 1). 40–40. 1 indexed citations
2.
Davis, C. Todd, et al.. (2001). Differential human immunodeficiency virus-suppressive activity of reverse transcription inhibitors in resting and activated peripheral blood lymphocytes: implications for therapy.. PubMed. 4(3). 113–22. 7 indexed citations
3.
Redfield, R, D L Birx, Nzeera Ketter, et al.. (1992). Vaccine Therapy Using rgp 160 in Early HIV Infection. AIDS Research and Human Retroviruses. 8(8). 1333–1333. 4 indexed citations
4.
Birx, D L, et al.. (1990). Abnormally elevated serum interleukin 6 levels in individuals with human immunodeficiency virus infection. Clinical research. 38(2). 350. 2 indexed citations
5.
Li, Gardner, et al.. (1990). The current distribution of CD4+ T-lymphocyte counts among adults in the United States with human immunodeficiency virus infections: estimates based on the experience of the U.S. Army. U.S. Army Retrovirus Research Group.. JAIDS Journal of Acquired Immune Deficiency Syndromes. 3(1). 92–4. 16 indexed citations
6.
Bender, Bradley S., et al.. (1986). Impaired antibody-dependent cell-mediated cytotoxic activity in patients with the acquired immunodeficiency syndrome.. PubMed. 64(1). 166–72. 20 indexed citations
8.
Shearer, G M, Daniel Bernstein, Charles S. Via, et al.. (1986). A model for the selective loss of major histocompatibility complex self-restricted T cell immune responses during the development of acquired immune deficiency syndrome (AIDS).. The Journal of Immunology. 137(8). 2514–2521. 184 indexed citations
9.
Benn, S, Audrey Kinter, J. Shawn Justement, et al.. (1986). Susceptibility of normal human lymphocytes to infection with HTLV-III/LAV.. The Journal of Immunology. 136(11). 4049–4053. 148 indexed citations
10.
Broder, Samuel, R Redfield, J E Groopman, et al.. (1985). EFFECTS OF SURAMIN ON HTLV-III/LAV INFECTION PRESENTING AS KAPOSI'S SARCOMA OR AIDS-RELATED COMPLEX: CLINICAL PHARMACOLOGY AND SUPPRESSION OF VIRUS REPLICATION IN VIVO. The Lancet. 326(8456). 627–630. 173 indexed citations
11.
Salahuddin, S. Zaki, R Redfield, Max Essex, et al.. (1984). HTLV-III IN SYMPTOM-FREE SERONEGATIVE PERSONS. The Lancet. 324(8417-8418). 1418–1420. 176 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026